One missed weekly injection
The label uses time until the next scheduled dose
The current manufacturer DailyMed set for Wegovy is Novo Nordisk semaglutide injection and tablet labeling effective June 18, 2026. For one missed Wegovy injection, it directs patients to look forward to the next scheduled weekly dose: when that dose is more than two days away, administer the missed injection as soon as possible; when it is less than two days away, do not administer the missed injection and resume on the regular weekly day. This is not a dose calculation or permission to add an injection.
- Use exact calendar dates and times rather than phrases such as “earlier this week” or “about two days.”
- Confirm the last injection actually taken because an uncertain record is different from a confirmed missed injection.
- The label wording does not resolve an uncertain or exactly-at-the-boundary calculation; ask the pharmacist or prescriber instead of rounding the interval.
Two or more missed weeks
Multiple consecutive missed injections need a restart plan
The professional labeling says that after two or more consecutive Wegovy injections are missed, dosage escalation is reinitiated at a lower dosage to reduce the risk of gastrointestinal adverse reactions. The Medication Guide tells patients who miss doses for two or more consecutive weeks to contact their healthcare provider about restarting. The label does not tell a patient to choose a lower strength independently, reuse an old pen, split a dose, or resume at a prior maintenance strength without review.
- Tell the prescriber how many weekly injections were missed, the last strength and presentation used, and why treatment was interrupted.
- Report nausea, vomiting, diarrhea, constipation, low intake, dehydration, abdominal pain, illness, a procedure, pregnancy, travel, storage, refill, or access problems that occurred during the gap.
- Do not use expired medication, damaged packaging, another person’s pen, an unlabeled vial, or a research-use product to fill the interruption.
Weekly-day changes
Moving the regular day is different from catching up
The current Medication Guide says the weekly injection day may be changed as long as the last Wegovy dose was given two or more days before. A planned day change, one missed injection, and a restart after multiple missed weeks are different situations. Combining those rules into a homemade calendar can create doses too close together or obscure which injection was actually administered.
- Record the new weekly day in the medication list, calendar, refill reminders, and care-team messages.
- Do not take an extra injection simply to return to a preferred weekday.
- If the last-dose time, next scheduled time, or new-day interval is uncertain, have the pharmacist or prescriber verify the calendar.
Route and product identity
Wegovy injection and Wegovy tablets have different missed-dose rules
The current Wegovy label includes once-weekly injection presentations and once-daily oral tablets. A missed tablet is skipped and the next tablet is taken the following day; that daily-tablet instruction must not be used for an injection. Wegovy, Ozempic, and compounded semaglutide can all involve semaglutide, but their brands, labeled uses, routes, strengths, presentations, and timing instructions are not interchangeable. A patient-specific compounded semaglutide preparation is not FDA-approved Wegovy or a generic Wegovy equivalent.
- Read the brand, route, labeler, presentation, strength, dispensing pharmacy, prescription date, and current directions before applying any missed-dose rule.
- Do not substitute a Wegovy tablet for a missed injection or overlap routes unless the prescriber has documented a label-based transition.
- Use the compounded prescription and dispensing-pharmacy label for compounded semaglutide questions; do not copy the Wegovy injection calendar automatically.
Symptoms and other medicines
A missed injection does not justify changing other treatment alone
A missed Wegovy injection can overlap with gastrointestinal symptoms, reduced food or fluid intake, illness, diabetes, insulin, a sulfonylurea, or another medicine. The Wegovy label includes warnings for severe gastrointestinal reactions, dehydration-related kidney injury, pancreatitis, gallbladder disease, hypoglycemia with certain glucose-lowering medicines, hypersensitivity, pregnancy, and delayed gastric emptying around anesthesia or deep sedation. A timing problem should not be used to invent a catch-up injection or independently alter another prescription.
- Share current symptoms, food and fluid intake, glucose or CGM readings when relevant, and the complete medication list with the responsible clinician.
- Do not stop, add, reduce, or increase insulin, a sulfonylurea, another GLP-1 medicine, or any prescribed treatment solely because Wegovy was missed.
- Use urgent or emergency care for severe or persistent abdominal pain, repeated vomiting with inability to keep fluids down, severe low-glucose symptoms, fainting, confusion, trouble breathing, facial or throat swelling, or another emergency pattern.
Safer access and follow-up
Reliable care verifies the product before answering the calendar question
A legitimate telehealth and pharmacy pathway should identify the exact Wegovy formulation, manufacturer packaging, prescriber, dispensing pharmacy, refill status, storage history, and contact route for missed injections. It should not sell an extra pen, an unlabeled compounded vial, or a research-use product as a quick schedule repair. Peptide12 lists clinician-reviewed branded Wegovy and compounded semaglutide pathways, but eligibility, the selected formulation, coverage, dispensing, and restart decisions are not guaranteed.
- Keep the carton, device, pharmacy label, lot information, dose record, and exact dates and times available when requesting help.
- Reject dose calculators, copied calendars, no-prescription checkout, hidden pharmacy sourcing, or compounded medication described as FDA-approved Wegovy.
- Ask how weekend timing questions, refill delays, travel, storage problems, side effects, procedures, and urgent symptoms are handled before treatment begins.